Genetic polymorphisms of CYP2A6 in a case-control study on bladder cancer in Japanese smokers

Masaki Kumondai, Hiroki Hosono, Kazuhiko Orikasa, Yoichi Arai, Tomio Arai, Haruhiko Sugimura, Seiichiro Ozono, Takayuki Sugiyama, Tatsuya Takayama, Takamitsu Sasaki, Noriyasu Hirasawa, Masahiro Hiratsuka

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Several of the procarcinogens inhaled in tobacco smoke, the primary risk factor for bladder cancer, are activated by CYP2A6. The association between the whole-gene deletion of CYP2A6 (CYP2A6∗4) and a reduced risk of bladder cancer was suggested in Chinese Han smokers. However, there is no evidence for association between the risk of bladder cancer and CYP2A6 genotypes in the Japanese population. Using genomic DNA from smokers of the Japanese population (163 bladder cancer patients and 116 controls), we conducted a case-control study to assess the association between CYP2A6 polymorphisms and the risk of bladder cancer. Determination of CYP2A6 genotypes was carried out by amplifying each exon of CYP2A6 using polymerase chain reaction (PCR) and Sanger sequencing. The CYP2A6∗4 allele was identified by an allelespecific PCR assay. Bladder cancer risk was evaluated using the activity score (AS) system based on CYP2A6 genotypes. The odds ratios (95% confidence interval) for the AS 0, AS 0.5, AS 1.0, and AS 1.5 groups were 0.46 (0.12-1.83), 0.43 (0.15-1.25), 0.86 (0.40-1.86), and 1.36 (0.60-3.06), respectively. In conclusion, although decreased CYP2A6 AS tended to reduce the risk of bladder cancer in Japanese smokers, no significant association was recognized in this population. However, given the relatively small size of the sample, further study is required to conclude the lack of a statistically significant association between CYP2A6 genotypes and the risk of bladder cancer.

Original languageEnglish
Pages (from-to)84-89
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Volume39
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1

Keywords

  • Bladder cancer
  • CYP2A6
  • Genetic polymorphism
  • Japanese
  • Smoking

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Genetic polymorphisms of CYP2A6 in a case-control study on bladder cancer in Japanese smokers'. Together they form a unique fingerprint.

  • Cite this

    Kumondai, M., Hosono, H., Orikasa, K., Arai, Y., Arai, T., Sugimura, H., Ozono, S., Sugiyama, T., Takayama, T., Sasaki, T., Hirasawa, N., & Hiratsuka, M. (2016). Genetic polymorphisms of CYP2A6 in a case-control study on bladder cancer in Japanese smokers. Biological and Pharmaceutical Bulletin, 39(1), 84-89. https://doi.org/10.1248/bpb.b15-00604